PROVIDER PROFILE · NPI 1437126018

Suzanne GeorgeMD

Hematology-OncologyBoston, MAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

Unique beneficiaries

—

Total services

144

Distinct HCPCS

Medicare payment

$10K

Peer benchmark

Total Medicare services vs. 360 Hematology-Oncology providers in MA — bottom quintile (cohort median 624).

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$39K

Distinct drugs

Brand share

0.0%

Top prescribed drugs

Imatinib Mesylate16 claims

QUALITY · MIPS · 2024

Final MIPS score

84.1

Quality

65.0

Cost

69.1

Improvement activities

40.0

Promoting interop.

100.0

Payment adjustment

0.38%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$37K

Payment records

By payment type

Consulting Fee$17K

Travel and Lodging$15K

Honoraria$5K

Food and Beverage$701

REFERRAL NETWORK

Where Suzanne George's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 5 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Nikhil Ramaiya Diagnostic Radiology · West Palm Beach, FL	34	115
Jyothipriya Jagannathan Diagnostic Radiology · Jamaica Plain, MA	28	116

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
DANA-FARBER CANCER INSTITUTE, INC.	140	1,569
BRIGHAM & WOMENS HOSPITAL, INC.	64	509
Katherine Krajewski Diagnostic Radiology · Boston, MA	16	39
Angela Giardino Diagnostic Radiology · Boston, MA	14	28
Michael Rosenthal Diagnostic Radiology · Boston, MA	13	87

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history